It had previously been reported that seropositivity to MDA5 in COVID-19 patients correlated with disease severity and unfavorable outcomes.[9] David et al. found a strong overlap between the surge in anti-MDA5 positive DM and the COVID-19 pandemic (Figure 1). Here, IFIH1 is linked to dermatomyositis.